A recent engadget article noted the first human Ebola vaccine to receive EU approval. Merck’s ERVEBO is the product of a unique collaboration between the Public Health Agency of Canada and the US Army over ten years ago. Merck acquired the rights to develop the vaccine after the 2014 Ebola outbreak in West Africa. On November 11th, the vaccine received a “conditional marketing authorization,” a distinction typically designated for medicines that treat unmet medical needs.
Quick Hits: EU Approves Human Ebola Vaccine
In a new first, Merck’s Ebola vaccine received a “conditional marketing authorization” from the European Union.
Nov 20, 2019
Fill out the form below to request more information about Quick Hits: EU Approves Human Ebola Vaccine
Recommended
Recommended
Recommended
Machinery Basics
Conveyor setup secrets from top CPG manufacturers
7 proven steps to eliminate downtime and boost packaging line efficiency. Free expert playbook reveals maintenance, sequencing, and handling strategies.
Read More
Annual Outlook Report: Sustainability
The road ahead for CPGs in 2025 and beyond—Packaging World editors review key findings from a survey of 88 brand owners, CPG, and FMCG readers.
Download Now
